Bioventus - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 247,177 | 286,265 | 251,220 | 312,442 | 628,220 | 722,321 | 906,533 | 930,161 |
| Profit before tax | 56,511 | 36,872 | 32,131 | 56,346 | 60,502 | 36,268 | 51,624 | 89,885 |
| Net profit | 47,144 | 31,017 | 27,176 | 45,844 | 51,222 | 30,632 | 43,771 | 75,633 |
| Equity | 110,728 | 121,372 | 148,548 | 182,067 | 237,198 | 267,830 | 271,498 | 347,130 |
| Liabilities | 155,846 | 164,939 | 185,886 | 32,997 | 77,053 | 2,144 | 26,370 | 58,267 |
| Non-current assets | 4,703 | 2,132 | 1,607 | 1,883 | 27,109 | 22,402 | 19,299 | 14,333 |
| Current assets | 261,869 | 284,005 | 332,489 | 213,147 | 286,771 | 247,238 | 278,171 | 390,700 |
| Total assets | 266,572 | 286,137 | 334,096 | 215,030 | 313,880 | 269,640 | 297,470 | 405,033 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 107,844 | 125,854 | 122,614 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -24.1% | +15.8% | -12.2% | +24.4% | +101.1% | +15.0% | +25.5% | +2.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.7% | 10.8% | 8.1% | 21.3% | 16.3% | 11.4% | 14.7% | 18.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 42.6% | 25.6% | 18.3% | 25.2% | 21.6% | 11.4% | 16.1% | 21.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 19.1% | 10.8% | 10.8% | 14.7% | 8.2% | 4.2% | 4.8% | 8.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 22.9% | 12.9% | 12.8% | 18.0% | 9.6% | 5.0% | 5.7% | 9.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.4 | 1.4 | 1.3 | 0.2 | 0.3 | 0.0 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 123,589 | 143,133 | 125,610 | 156,221 | 314,110 | 361,161 | 453,267 | 465,081 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioventus - Social security debts
The company had no debts to Sodra
Bioventus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-01 | 2026-01-20 | 1.12 |
| 2025-12-18 | 2025-12-18 | 2102.96 |
| 2025-11-27 | 2025-12-17 | 8.96 |
| 2025-10-30 | 2025-11-26 | 9.84 |
| 2025-09-30 | 2025-10-18 | 5.46 |
| 2025-09-28 | 2025-09-29 | 6300.2 |
| 2025-06-19 | 2025-06-19 | 1805.17 |
| 2025-04-03 | 2025-04-09 | 0.39 |
| 2025-04-02 | 2025-04-02 | 93.74 |
| 2025-03-27 | 2025-04-01 | 93.59 |
| 2025-03-26 | 2025-03-26 | 93.35 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioventus, UAB (code 120895162) is a Private Limited Liability Company operating in the wholesale of wood, construction materials and sanitary equipment. In 2025, revenue reached €930.2K, increasing by 2.6% year on year and by 28.8% compared with two years earlier. Net profit amounted to €75.6K, up from €43.8K in 2024 and €30.6K in 2023, which shows a steady improvement in profitability over the three-year period. The profit margin rose from 4.2% in 2023 to 4.8% in 2024 and 8.1% in 2025. Total assets increased to €405.0K in 2025 from €297.5K in 2024, driven mainly by short-term assets of €390.7K, while long-term assets stood at €14.3K. Equity strengthened to €347.1K and liabilities increased to €58.3K, resulting in an equity ratio of 85.7% and debt-to-equity of 0.17. Return on equity was 21.8%, return on assets 18.7%, and asset turnover 2.30x. Revenue per employee was €465.1K, with profit per employee of €37.8K, indicating strong productivity.